APP
-
siRNA Therapeutics Targeting APP for Alzheimer’s Disease (AD) 【Product for Licensing】
If you are interested in this asset or need more information, please kindly contact DrugTimes BD Team at BD@drugtimes.cn, we will present the non-confidential deck to you for review asap. Many thanks!~
